CS logo
small CS logo
Gastroenterology Associates of Northern Virginia

Fairfax, Virginia, United States

About Gastroenterology Associates of Northern Virginia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Gastroenterology Associates of Northern Virginia


During the past decade, Gastroenterology Associates of Northern Virginia conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Gastroenterology Associates of Northern Virginia" #1 sponsor was "Pfizer" with 3 trials, followed by "Millennium Pharmaceuticals, Inc." with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Coronado Biosciences, Inc." with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

Clinical Trials Conditions at Gastroenterology Associates of Northern Virginia


According to Clinical.Site data, the most researched conditions in "Gastroenterology Associates of Northern Virginia" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Irritable Bowel Syndrome With Diarrhea" (1 trials), "Moderate to Severe Ulcerative Colitis" (1 trials) and "NASH - Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Gastroenterology Associates of Northern Virginia" in a lesser frequency.

Clinical Trials Intervention Types at Gastroenterology Associates of Northern Virginia


Most popular intervention types in "Gastroenterology Associates of Northern Virginia" are "Drug" (10 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "vedolizumab" (2 trials), "0 mg Induction ONLY" (1 trials), "150 mg Induction/Chronic" (1 trials) and "450 mg Induction/Chronic" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Gastroenterology Associates of Northern Virginia


The vast majority of trials in "Gastroenterology Associates of Northern Virginia" are 11 trials for "All" genders.

Clinical Trials Status at Gastroenterology Associates of Northern Virginia


Currently, there are NaN active trials in "Gastroenterology Associates of Northern Virginia". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Gastroenterology Associates of Northern Virginia, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Gastroenterology Associates of Northern Virginia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".